Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation
Chaoyun Pan(Emory University), Sumin Kang(Emory University), Sagar Lonial(Emory University), Nabil F. Saba(Emory University), Kelly R. Magliocca(Emory University), Jaemoo Chun(Korea Institute of Oriental Medicine), Zhuo G. Chen(Emory University), Austin C. Boese(Emory University), Dan Li(Harbin University of Commerce), Jie Li(Nanjing University of Chinese Medicine), Lina Song(Hubei University of Medicine), Yunhan Jiang(The University of Texas Health Science Center at San Antonio), JiHoon Kang(Yale New Haven Hospital), Lingtao Jin(Emory University), Anna D. Umano(Emory University), Dong Mi Shin, Taofeek K. Owonikoko(UPMC Hillman Cancer Center)
Cited by 44
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k